Chick CAM Assay: Blood Vessel Inhibition Zones for N2 and Bevacizumab

Nawar Raad Hussein published a 5.5 KB Excel file on figshare in May 2026. The dataset contains measurements from a chick chorioallantoic membrane assay, specifically the zone of inhibition of blood vessel growth. It compares the effects of a compound labeled N2 against the positive control Bevacizumab, with six replicates per treatment group.

Use Cases

• Compare anti-angiogenic efficacy based on zone of inhibition measurements.
• Benchmark novel compounds like N2 against established controls such as Bevacizumab.
• Validate the chick CAM assay protocol using quantified inhibition zones.

Strengths

• Data is structured for direct comparison between N2 and Bevacizumab treatment groups.
• The dataset includes six biological replicates per group, a standard for preliminary studies.
• It is published under a permissive CC-BY-4.0 license for reuse.

Limitations

• The dataset is very small at 5.5 KB, indicating limited scope.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Data likely originates from laboratory experiments using the chick chorioallantoic membrane (CAM) assay.

Freshness

Last updated 2026-05-14 17:32:19; freshness should be verified.